Singapore: Australian technology company, Global Kinetics Corporation (GKC), is set to roll out a new mobile health technology capable of measuring Parkinson's disease symptoms.

Mr Andrew Maxwell, managing director, GKC stated that the Parkinson's KinetiGraph is already available to over 50,000 people with Parkinson's across Europe, Australia and Asia it is anticipated that patients in 30 nations worldwide will have access to PKG technology within 18 months.

Mr Maxwell was responding to reports that global communications giant Intel is collaborating with Michael J Fox Foundation to develop wearable gadgets to monitor patients with Parkinson's disease.

He said, "We are pleased that the Michael J Fox Foundation and Intel, like GKC, has recognized the opportunity for people with Parkinson's to receive better care, when that care is informed by objective measurement. Our company was founded by leading Australian neurologists and brain researchers who recognized that clinicians require actionable information to inform their patient management."

"US is our next frontier, we expect FDA approval shortly and we are looking forward to working with US clinicians, patient advocacy groups and industry players," Mr Maxwell informed.

The technology has been developed by Australian neurologists at the Melbourne based Florey Institute of Neuroscience and Mental Health and is now being rolled out by Global Kinetics Corporation.